fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

ILTS 2012 Report – Regulatory T-cell injection holds promise for inducing tolerance

Written by | 28 Jun 2012

by Thomas R. Collins – Injection of regulatory T cells could prove to be a powerful method of inducing tolerance among liver transplantation patients,

ILTS 2012 Report – New Hepatitis C treatments may improve outlook

Written by | 28 Jun 2012

by Thomas R. Collins – The state of treatment for Hepatitis C patients waiting for a liver transplant leaves a lot to be desired

How the donors have changed in the last ten years

Written by | 28 Jun 2012

Dr Irene Scalera, Fellow at the Liver Unit at Queen Elizabeth Hospital, Birmingham, describes the ever-changing donor landscape and attempts to improve liver donor shortage.

Abuse of opioid drugs linked to mood and anxiety disorders

Written by | 14 Jun 2012

Mood and anxiety disorders such as bipolar, panic disorder and major depressive disorder appear to be highly associated with non-medical prescription opioid use.

Duloxetine appears to relieve chemotherapy-related neuropathic pain

Written by | 14 Jun 2012

Paper presented on 5th June at ASCO – by Bruce Sylvester – The antidepressant duloxetine (Cymbalta ®), relieves  neuropathic pain caused by chemotherapy in 59 percent of patients,… read more.

Tocilizumab is more effective than adalimumab at reducing signs and symptoms of RA

Written by | 14 Jun 2012

Safety results were similar between groups. Data presented at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that tocilizumab monotherapy is more effective than… read more.

Green light for new medicines

Written by | 14 Jun 2012

Emerging uses of EMA Approved Drugs – by Gary Finnegan – Several new medicines have been approved by the European Medicines Agency after recent meetings of its Committee… read more.

How should advanced therapies be classified?

Written by | 14 Jun 2012

Emerging uses of EMA Approved Drugs – by Gary Finnegan – The EMA has launched a public consultation on the classification of advanced therapies.

Tough times for medicines regulator

Written by | 14 Jun 2012

Emerging uses of EMA Approved Drugs – by Gary Finnegan – The European Medicines Agency is emerging from a turbulent spell which has seen the departure of one… read more.

Ipilimumab looks promising in shrinking/slowing melanoma brain metastases

Written by | 14 Jun 2012

Emerging uses of FDA Approved Drugs – by Bruce Sylvester – Researchers from a phase 2 study published  on March 27 in The Lancet Oncology  report that ipilimumab,… read more.

Largest study to date confirms efficacy of botulinum toxin treatment for overactive bladder

Written by | 14 Jun 2012

Emerging uses of FDA Approved Drugs – by Bruce Sylvester – Results from the largest study yet of the treatment of urinary incontinence with botulinum toxin suggests that… read more.

Statins appear to lower depression risk among heart disease patients

Written by | 14 Jun 2012

Emerging uses of FDA Approved Drugs – by Bruce Sylvester – Heart disease patients who use statins are significantly less likely to develop depression than their counterparts who… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.